Astrocyte‐derived kynurenic acid modulates basal and evoked cortical acetylcholine release
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
We tested the hypothesis that fluctuations in the levels of kynurenic acid (KYNA), an endogenous antagonist of the α7 nicotinic acetylcholine (ACh) receptor, modulate extracellular ACh levels in the medial prefrontal cortex in rats. Decreases in cortical KYNA levels were achieved by local perfusion of S‐ESBA, a selective inhibitor of the astrocytic enzyme kynurenine aminotransferase II (KAT II), which catalyses the formation of KYNA from its precursor l‐kynurenine. At 5 m m, S‐ESBA caused a 30% reduction in extracellular KYNA levels, which was accompanied by a two‐threefold increase in basal cortical ACh levels. Co‐perfusion of KYNA in the endogenous range (100 n m), which by itself tended to reduce basal ACh levels, blocked the ability of S‐ESBA to raise extracellular ACh levels. KYNA perfusion (100 n m) also prevented the evoked ACh release caused by d‐amphetamine (2.0 mg/kg). This effect was duplicated by the systemic administration of kynurenine (50 mg/kg), which resulted in a significant increase in cortical KYNA formation. Jointly, these data indicate that astrocytes, by producing and releasing KYNA, have the ability to modulate cortical cholinergic neurotransmission under both basal and stimulated conditions. As cortical KYNA levels are elevated in individuals with schizophrenia, and in light of the established role of cortical ACh in executive functions, our findings suggest that drugs capable of attenuating the production of KYNA may be of benefit in the treatment of cognitive deficits in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297 · cited 2×
“The pathophysiology of these broad and fundamental deficits is intricate and involves numerous brain regions, including the hippocampus (Boyer et al., 2007), the frontal cortex (Lewis et al., 2005; Sarter et al., 2005; Tan et al., 2007), and the striatal complex (Laruelle et al., 2003).”
BackgroundNicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System
Dani, J. A., & Bertrand, D. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105214 · Cited by 1,197
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Coyle, J. T. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9062-8 · Cited by 917 · cited 4×
“…neurotransmitter systems, including dopamine (Laruelle et al., 2003; Toda & Abi-Dargham, 2007), glutamate (Krystal et al., 2003; Moghaddam, 2003; Coyle, 2006), c-aminobutyric acid (GABA) (Lewis & Moghaddam, 2006), and acetylcholine (ACh) (Hyde & Crook, 2001; Sarter et al., 2005), throughout a…”
BackgroundInfluentialIncreased cortical kynurenate content in schizophrenia
Schwarcz, R., Rassoulpour, A., Wu, H.-Q., Medoff, D., Tamminga, C. A., & Roberts, R. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01078-2 · Cited by 590
Self-citationKrystal, J. H., D'Souza, D. C., Mathalon, D., Perry, E., Belger, A., & Hoffman, R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1582-z · Cited by 530
Glutamate, Dopamine, and Schizophrenia: From Pathophysiology to Treatment
LARUELLE, M., KEGELES, L. S., & ABI‐DARGHAM, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.063 · Cited by 437
Cognitive Dysfunction in Schizophrenia: Convergence of γ-Aminobutyric Acid and Glutamate Alterations
Lewis, D. A., & Moghaddam, B. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1372 · Cited by 404 · cited 4×
“Likewise, impaired executive functions in schizophrenia have been linked to dysregulations in various neurotransmitter systems, including dopamine (Laruelle et al., 2003; Toda & Abi-Dargham, 2007), glutamate (Krystal et al., 2003; Moghaddam, 2003; Coyle, 2006), c-aminobutyric acid (GABA) (Lewis & Moghaddam, 2006), and…”
InfluentialEffects of dextroamphetamine on cognitive performance and cortical activation
Mattay, V. S., Callicott, J. H., Bertolino, A., Heaton, I., Frank, J. A., Coppola, R., Berman, K. F., Goldberg, T. E., & Weinberger, D. R. (2000) · NeuroImage · doi:10.1006/nimg.2000.0610 · Cited by 296 · cited 2×
“However, we chose d-amphetamine also for its pro-cognitive properties, which involve the PFC (Mattay et al., 2000), as well as the fact that the drug’s effect on cortical ACh may be mediated indirectly through the release of glutamate (Giovannini et al., 1997; Del Arco & Mora, 2005; Parikh et al.,…”
MethodTan, H.-Y., Callicott, J. H., & Weinberger, D. R. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm069 · Cited by 266
Mechanisms underlying working memory for novel information
Hasselmo, M. E., & Stern, C. E. (2006) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2006.09.005 · Cited by 249
Cited by
Verkhratsky, A., & Nedergaard, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2016 · Cited by 1,678
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
Self-citationTryptophan-kynurenine pathway is dysregulated in inflammation and immune activation
Zou, M.-H. (2015) · Frontiers in Bioscience · doi:10.2741/4363 · Cited by 361
Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
Linderholm, K. R., Skogh, E., Olsson, S. K., Dahl, M.-L., Holtze, M., Engberg, G., Samuelsson, M., & Erhardt, S. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq086 · Cited by 325
Kynurenine pathway in depression: a systematic review and meta-analysis
Ogyu, K., Kubo, K., Noda, Y., Iwata, Y., Tsugawa, S., Omura, Y., Wada, M., Tarumi, R., Plitman, E., Moriguchi, S., et al. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.023 · Cited by 301
Metadata
- Authors
- Zmarowski, A., Wu, H. ‐., Brooks, J. M., Potter, M. C., Pellicciari, R., Schwarcz, R., & Bruno, J. P.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2009-02
- Volume
- 29
- Issue
- 3
- Pages
- 529-538
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2154565921
- Cited by
- 122
- References
- 18
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Astrocyte‐derived kynurenic acid modulates basal and evoked cortical acetylcholine release. https://app.cochat.ai/papers/10.1111/j.1460-9568.2008.06594.x
- The paper
- Zmarowski, A., Wu, H. ‐., Brooks, J. M., Potter, M. C., Pellicciari, R., Schwarcz, R., & Bruno, J. P. (2009). Astrocyte‐derived kynurenic acid modulates basal and evoked cortical acetylcholine release. European Journal of Neuroscience. https://doi.org/10.1111/j.1460-9568.2008.06594.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.